Moleculin Biotech, Inc. (MBRX)
0.7659
+0.02
(+2.11%)
USD |
NASDAQ |
Sep 09, 14:00
Moleculin Biotech Price to Book Value : 0.4693 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 0.4596 |
| September 04, 2026 | 0.435 |
| September 03, 2026 | 0.4139 |
| September 02, 2026 | 0.4253 |
| September 01, 2026 | 0.3983 |
| August 31, 2026 | 0.395 |
| August 28, 2026 | 0.3982 |
| August 27, 2026 | 0.422 |
| August 26, 2026 | 0.3677 |
| August 25, 2026 | 0.3744 |
| August 24, 2026 | 0.3734 |
| August 21, 2026 | 0.3634 |
| August 20, 2026 | 0.3619 |
| August 19, 2026 | 0.3505 |
| August 18, 2026 | 0.3738 |
| August 17, 2026 | 0.3719 |
| August 14, 2026 | 0.3751 |
| August 13, 2026 | 0.3501 |
| August 12, 2026 | 0.32 |
| August 11, 2026 | 0.2727 |
| August 10, 2026 | 0.2637 |
| August 07, 2026 | 0.2509 |
| August 06, 2026 | 0.2359 |
| August 05, 2026 | 0.239 |
| August 04, 2026 | 0.2509 |
| Date | Value |
|---|---|
| August 03, 2026 | 0.2604 |
| July 31, 2026 | 0.2451 |
| July 30, 2026 | 0.625 |
| July 29, 2026 | 0.8333 |
| July 28, 2026 | 1.342 |
| July 27, 2026 | 1.342 |
| July 24, 2026 | 1.299 |
| July 23, 2026 | 1.274 |
| July 22, 2026 | 1.287 |
| July 21, 2026 | 1.317 |
| July 20, 2026 | 1.311 |
| July 17, 2026 | 1.287 |
| July 16, 2026 | 1.330 |
| July 15, 2026 | 1.416 |
| July 14, 2026 | 1.385 |
| July 13, 2026 | 1.354 |
| July 10, 2026 | 1.397 |
| July 09, 2026 | 1.495 |
| July 08, 2026 | 1.452 |
| July 07, 2026 | 1.422 |
| July 06, 2026 | 1.471 |
| July 02, 2026 | 1.618 |
| July 01, 2026 | 1.648 |
| June 30, 2026 | 1.710 |
| June 29, 2026 | 1.255 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.669 |
| Alnylam Pharmaceuticals, Inc. | 25.18 |
| Anika Therapeutics, Inc. | 2.037 |
| Savara, Inc. | 7.714 |
| Vericel Corp. | 5.364 |
Price to Book Value Related Metrics
| Price | 0.7659 |
| Earnings Yield | -2.24K% |
| Market Cap | 5.438M |